Organocatalytic removal of formaldehyde adducts from RNA and DNA bases

  • A Corrigendum to this article was published on 20 November 2015

Abstract

Formaldehyde is universally used to fix tissue specimens, where it forms hemiaminal and aminal adducts with biomolecules, hindering the ability to retrieve molecular information. Common methods for removing these adducts involve extended heating, which can cause extensive degradation of nucleic acids, particularly RNA. Here, we show that water-soluble bifunctional catalysts (anthranilates and phosphanilates) speed the reversal of formaldehyde adducts of mononucleotides over standard buffers. Studies with formaldehyde-treated RNA oligonucleotides show that the catalysts enhance adduct removal, restoring unmodified RNA at 37 °C even when extensively modified, while avoiding the high temperatures that promote RNA degradation. Experiments with formalin-fixed, paraffin-embedded cell samples show that the catalysis is compatible with common RNA extraction protocols, with detectable RNA yields increased by 1.5–2.4-fold using a catalyst under optimized conditions and by 7–25-fold compared with a commercial kit. Such catalytic strategies show promise for general use in reversing formaldehyde adducts in clinical specimens.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Formaldehyde adducts and catalysts investigated in this study.
Figure 2: Relative rates of formaldehyde adduct reversal.
Figure 3: Relative yields of adduct reversal from nucleotides after 1 h with catalyst 3 and with analogues with functional groups omitted (structures shown).
Figure 4: Assessing formaldehyde adducts on an RNA strand by mass spectrometry.
Figure 5: Improvement in reversal of RNA formaldehyde adducts after low-temperature incubation in the presence of catalyst 3.
Figure 6: Enhancement in recovery of RNAs from FFPE cell specimens using catalyst 3 (20 mM) as compared with different incubation and isolation conditions.

Change history

  • 27 October 2015

    In the original version of this Article a contributing author, Florian Scherer, was mistakenly omitted. Florian Scherer is in the Divisions of Oncology and of Hematology, Stanford School of Medicine, Stanford, California 94305, USA. This mistake has been corrected in all online versions of the Article.

References

  1. 1

    Sotiriou, C. & Piccart, M. J. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nature Rev. Cancer 7, 545–553 (2007).

  2. 2

    Chin, L. & Gray, J. W. Translating insights from the cancer genome into clinical practice. Nature 452, 553–563 (2014).

  3. 3

    Fairley, J. A., Gilmour, K. & Walsh, K. Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue. Curr. Drug Targets 13, 1475–1487 (2012).

  4. 4

    McGhee, J. D. & von Hippel, P. H. Formaldehyde as a probe of DNA structure. I. Reaction with exocyclic amino groups of DNA bases. Biochemistry 14, 1281–1296 (1975).

  5. 5

    Krafft, A. E., Duncan, B. W., Bijwaard, K. E., Taubenberger, J. K. & Lichy, J. H. Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: The Armed Forces Institute of Pathology experience and literature review. Mol. Diagn. 2, 217–230 (1997).

  6. 6

    Okello, J. B. et al. Comparison of methods in the recovery of nucleic acids from archival formalin-fixed paraffin-embedded autopsy tissues. Anal. Biochem. 400, 110–117 (2010).

  7. 7

    Páska, C. et al. Effect of formalin, acetone, and RNAlater fixatives on tissue preservation and different size amplicons by real-time PCR from paraffin-embedded tissue. Diagn. Mol. Pathol. 13, 234–240 (2004).

  8. 8

    Linton, K. M. et al. Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours. Br. J. Cancer 98, 1403–1414 (2008).

  9. 9

    Shi, S. R., Shi, Y. & Taylor, C. R. Antigen retrieval immunohistochemistry review and future prospects in research and diagnosis over two decades. J. Histochem. Cytochem. 59, 13–32 (2011).

  10. 10

    Chen, J., Byrne, G. E. Jr & Lossos, I. S. Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues. Diagn. Mol. Pathol. 16, 61–72 (2007).

  11. 11

    Gilbert, M. T. et al. The isolation of nucleic acids from fixed, paraffin-embedded tissues—which methods are useful when? PLoS ONE 2, e537 (2007).

  12. 12

    Lindahl, T. Instability and decay of the primary structure of DNA. Nature 362, 709–715 (1993).

  13. 13

    Kubista, M., Björkman, J., Svec, D. & Sjöback, R. RNA quality matters. Eur. Pharm. Rev. 17, 63–67 (2012).

  14. 14

    Jencks, W. P. Mechanism and catalysis of simple carbonyl group reactions. Prog. Phys. Org. Chem. 2, 63 (1964).

  15. 15

    Jencks, W. P. Studies on the mechanism of oxime and semicarbazone formation. J. Am. Chem. Soc. 81, 475–481 (1959).

  16. 16

    Cordes, E. H. & Jencks, W. P. Nucleophilic catalysis of semicarbazone formation by anilines. J. Am. Chem. Soc. 84, 826–831 (1962).

  17. 17

    Wendeler, M., Grinberg, L., Wang, X., Dawson, P. E. & Baca, M. Enhanced catalysis of oxime-based bioconjugations by substituted anilines. Bioconj. Chem. 25, 93–101 (2014).

  18. 18

    Rashidian, M. et al. A highly efficient catalyst for oxime ligation and hydrazone–oxime exchange suitable for bioconjugation. Bioconj. Chem. 24, 333–342 (2013).

  19. 19

    Crisalli, P. & Kool, E. T. Water-soluble organocatalysts for hydrazone and oxime formation. J. Org. Chem. 78, 1184–1189 (2013).

  20. 20

    Crisalli, P. & Kool, E. T. Importance of ortho proton donors in catalysis of hydrazone formation. Org. Lett. 15, 1646–1649 (2013).

  21. 21

    Rait, V. K., Zhang, Q., Fabris, D., Mason, J. T. & O'Leary, T. J. Conversions of formaldehyde-modified 2′-deoxyadenosine 5′-monophosphate in conditions modeling formalin-fixed tissue dehydration. J. Histochem. Cytochem. 54, 301–310 (2006).

  22. 22

    Chaw, Y. F., Crane, L. E., Lange, P. & Shapiro, R. Isolation and identification of cross-links from formaldehyde-treated nucleic acids. Biochemistry 19, 5525–5531 (1980).

  23. 23

    Dirksen, A., Dirksen, S., Hackeng, T. M. & Dawson, P. E. Nucleophilic catalysis of hydrazone formation and transimination: implications for dynamic covalent chemistry. J. Am. Chem. Soc. 128, 15602–15603 (2006).

  24. 24

    Rowland, G. B. et al. Brønsted acid-catalyzed imine amidation. J. Am. Chem. Soc. 127, 15696–15697 (2005).

  25. 25

    Kerick, M. et al. Targeted high-throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med. Genomics 4, 68 (2011).

  26. 26

    Montgomery, K., Zhao, S., van de Rijn, M. & Natkunam, Y. A novel method for making ‘tissue’ microarrays from small numbers of suspension cells. Appl. Immunohistochem. Mol. Morphol. 13, 80–84 (2005).

  27. 27

    Karpova, M. B. et al. Raji revisited: cytogenetics of the original Burkitt's lymphoma cell line. Leukemia 19, 159–161 (2005).

  28. 28

    Masuda, N., Ohnishi, T., Kawamoto, S., Monden, M. & Okubo, K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res. 27, 4436–4443 (1999).

  29. 29

    Lindahl, T. & Nyberg, B. Rate of depurination of native deoxyribonucleic acid. Biochemistry 11, 3610–3618 (1972).

  30. 30

    Brisco, M. J. & Morley, A. A. Quantification of RNA integrity and its use for measurement of transcript number. Nucleic Acids Res. 40, e144 (2012).

  31. 31

    Gingrich, J., Rubio, T. & Karlak, C. Effect of RNA Degradation on Data Quality in Quantitative PCR and Microarray Experiments Technical Report 5452A (Bio-Rad, 2006).

  32. 32

    Asslaber, M. et al. The genome Austria tissue bank (GATiB). Pathobiology 74, 251–258 (2007).

Download references

Acknowledgements

The authors acknowledge support from the US National Institutes of Health (GM068122 and GM110050, to E.T.K.) and the Lymphoma Research Foundation (LRF#245480, to A.A.A.). E.M.H. acknowledges funding from a National Science Foundation (NSF) graduate fellowship (DGE-1147470) and L.B. and C.R. acknowledge support from the Swiss National Science Foundation. D.S.H. has received funding from the Stanford ChEM-H Institute and T.E. acknowledges support from the Deutscher Akademischer Austauschdienst. The authors thank D. Winant for assistance with MALDI analysis of RNAs and R. Krishnan and F. Scherer for assistance with the cell samples and RNA isolation.

Author information

E.T.K. designed the project and A.A.A., A.F.L. and D.M.K. designed the cell studies. S.K., E.M.H. and D.S.H. carried out the experiments, with early exploratory studies carried out by T.E. Catalyst 3 was synthesized by S.K. and L.J.B. and RNA was prepared by C.R. The manuscript was written by E.T.K. with input from E.M.H., S.K., A.A.A. and D.S.H.

Correspondence to Eric T. Kool.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information

Supplementary information (PDF 1799 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Karmakar, S., Harcourt, E., Hewings, D. et al. Organocatalytic removal of formaldehyde adducts from RNA and DNA bases. Nature Chem 7, 752–758 (2015). https://doi.org/10.1038/nchem.2307

Download citation

Further reading